![No image](https://static.cymitquimica.com/public/img/category-default-logo.png)
Vorolanib and Impurities
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 4Z-V-094002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 8 Jul 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 4Z-V-094001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 8 Jul 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Vorolanib
CAS:1013920-15-4
Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor.
Formula:
C23H26FN5O3
Purity:
98.73%
Color and Shape:
Solid
Molecular weight:
439.48
Ref: TM-T8491
1mg | 111.00 € | ||
5mg | 230.00 € | ||
10mg | 369.00 € | ||
25mg | 618.00 € | ||
50mg | 877.00 € | ||
100mg | 1,189.00 € | ||
1ml*10 (DMSO) | 253.00 € |
Estimated delivery in United States, on Monday 8 Jul 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 4Z-V-094003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 8 Jul 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Ref: 4Z-V-094004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 8 Jul 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Alobresib
CAS:1637771-14-2
Alobresib (Vorolanib) is an inhibitor of BET bromodomain,is an antineoplastic drug candidate.
Formula:
C26H23N5O2
Purity:
98.87%
Color and Shape:
Solid
Molecular weight:
437.49
Ref: TM-T8495
1mg | 72.00 € | ||
2mg | 91.00 € | ||
5mg | 142.00 € | ||
10mg | 269.00 € | ||
25mg | 525.00 € | ||
50mg | 737.00 € | ||
100mg | 1,013.00 € | ||
1ml*10 (DMSO) | 156.00 € |
Estimated delivery in United States, on Monday 8 Jul 2024